This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Bayer Healthcare LLC, Talecris Biotherapeutics, Inc.. Active years: 2005-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2009
Title: **Marina N Korneyeva: Pioneering Innovation in Thrombolytic Therapy**
Introduction
Marina N Korneyeva is an accomplished inventor based in Raleigh, NC, known for her significant contributions to the field of biotherapeutics. With a portfolio of two patents, Korneyeva's work focuses on the production processes of specialized medical formulations that have the potential to enhance thrombolytic therapies.
Latest Patents
Korneyeva’s latest patents showcase her innovative approach to improving medical treatments. One of her noteworthy patents is centered on the "Process for the production of a reversibly inactive acidified plasmin composition." This invention discloses a method for activating plasminogen to produce a reversibly inactive acidified plasmin, which is formulated with a low pH-buffering capacity agent. This stable formulation allows for the effective administration of thrombolytic therapy.
Another significant patent involves the "Sanitization of chromatographic media." This method provides a novel approach to sanitizing chromatographic media by utilizing an acidic chaotropic agent at low temperature and low pH, effectively ensuring pathogen removal and/or inactivation, including viral inactivation.
Career Highlights
Korneyeva has an impressive career, having worked for leading companies in the biopharmaceutical sector, including Talecris Biotherapeutics, Inc. and Bayer Healthcare LLC. Her roles in these organizations have contributed to the advancement of therapeutic technologies and processes that care for patients.
Collaborations
Throughout her career, Korneyeva has collaborated with several esteemed colleagues, including James Rebbeor and Christopher J Stenland. These partnerships reflect her commitment to fostering innovation and advancing research in her field.
Conclusion
Marina N Korneyeva's work stands as a testament to the impact of innovative thinking in biomedicine. Her patents not only underline her expertise as an inventor but also demonstrate her dedication to enhancing therapeutic options through rigorous scientific research and collaboration. With her ongoing contributions, Korneyeva continues to drive advancements in thrombolytic therapy and related fields.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile